Jonathan Bohmann

Bohmann, who works for the Southwest Research Institute in San Antonio, TX, is a staff scientist for a COVID-19 drug discovery project in partnership with the Department of Defense. The project is using DoD supercomputers to quickly screen drug compounds that may treat COVID-19. The work is funded by a one-year $1.9 million contract from the Henry M. Jackson Foundation for the Advancement of Military Medicine, and makes use of a 3D drug screening software tool that Bohmann authored, Rhodium™, which predicts how protein structures in infectious diseases bind with drug compounds.